Lazzeri Domar Niccolò, Botti Giovanni, Botti Chiara
Department of Plastic and Reconstructive Surgery, Catholic University of Sacro Cuore, University Hospital A. Gemelli, Rome, Italy.
Villa Bella Clinic, Salò, Italy.
Aesthetic Plast Surg. 2025 Sep 19. doi: 10.1007/s00266-025-05235-7.
Postoperative hematoma remains one of the most significant complications in rhytidectomy, with reported rates up to 15%. This study presents a structured, experience-based protocol for hematoma prevention, developed over 40 years and applied to over 3000 cervicofacial lift procedures. The protocol combines strict patient selection, advanced surgical technique, and perioperative management strategies aimed at minimizing bleeding risks.
A retrospective analysis was conducted on a patient population of approximately 3000 individuals, with an emphasis on the most recent 500 cases performed under a unified protocol. Key preoperative measures include blood pressure control and avoidance of medications and supplements that increase bleeding risk. Intraoperative strategies involve infiltration with tranexamic acid (TXA), use of fibrin sealants (ARTISS), hemostatic net placement, and meticulous SMAS flap dissection and fixation using a modified High SMAS/Extended SMAS technique. Postoperative care focuses on pain, anxiety, and blood pressure control through long-acting anesthetics and appropriate dressings.
The systematic adoption of this multimodal approach has reduced the hematoma rate to approximately 0.3% over the past five years. The combination of TXA, fibrin glue, hemostatic nets, and blood pressure management has proven synergistically effective, despite the lack of randomized controlled comparisons.
While the study is limited by its retrospective design and absence of a formal control group, the large sample size and low complication rate offer compelling evidence. This protocol represents a reproducible and practical guide for surgeons aiming to minimize hematoma risk in facelift surgery, supporting safer outcomes and faster recovery. A standardized, multimodal protocol has reduced hematoma rates in facelift surgery to 0.3%. The protocol integrates TXA infiltration, fibrin glue, hemostatic nets, and precise blood pressure control. Over 3000 facelift cases and 40 years of experience support the safety and reproducibility of the approach. This guide provides practical steps that can be directly applied to improve surgical outcomes in rhytidectomy.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
术后血肿仍然是除皱术中最严重的并发症之一,报道的发生率高达15%。本研究提出了一种基于经验的结构化血肿预防方案,该方案历经40多年发展而成,并应用于3000多例面颈部提升手术。该方案结合了严格的患者选择、先进的手术技术以及旨在将出血风险降至最低的围手术期管理策略。
对约3000例患者进行了回顾性分析,重点关注按照统一方案进行的最近500例病例。术前关键措施包括控制血压以及避免使用增加出血风险的药物和补充剂。术中策略包括使用氨甲环酸(TXA)浸润、使用纤维蛋白封闭剂(ARTISS)、放置止血网以及采用改良的高位SMAS/扩展SMAS技术细致地进行SMAS瓣的分离和固定。术后护理通过长效麻醉剂和适当的敷料重点关注疼痛、焦虑和血压控制。
在过去五年中,系统采用这种多模式方法已将血肿发生率降至约0.3%。尽管缺乏随机对照比较,但TXA、纤维蛋白胶、止血网和血压管理的联合使用已证明具有协同效果。
虽然该研究受其回顾性设计和缺乏正式对照组的限制,但大样本量和低并发症发生率提供了有力证据。该方案为旨在将面部提升手术中血肿风险降至最低的外科医生提供了一个可重复且实用的指南,有助于实现更安全的手术结果和更快的恢复。一种标准化的多模式方案已将面部提升手术中的血肿发生率降至0.3%。该方案整合了TXA浸润、纤维蛋白胶、止血网和精确的血压控制。3000多例面部提升病例和40年的经验支持了该方法的安全性和可重复性。本指南提供了可直接应用于改善除皱手术手术结果的实用步骤。
证据水平III:本刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266 。